Dose-Response Relationship, DrugDrug Administration ScheduleAntineoplastic AgentsRadiation DosageDrug Screening Assays, AntitumorCell Line, TumorRadiation, IonizingNeoplasmsRadiation InjuriesDoxorubicinDose-Response Relationship, RadiationApoptosisDrug Resistance, NeoplasmRadiation ToleranceAntineoplastic Agents, PhytogenicRadiationCell SurvivalAntibiotics, AntineoplasticCisplatinDrug Delivery SystemsRadiation MonitoringRadiation ProtectionDrug CarriersTumor Cells, CulturedXenograft Model Antitumor AssaysMice, NudeEllipticinesCell ProliferationCamptothecinEtoposidePaclitaxelDNA DamageDrug Resistance, MultipleInhibitory Concentration 50P-GlycoproteinMolecular StructureDrug SynergismDrug DesignRadiation OncologyGamma RaysCell CycleProdrugsDNA Topoisomerases, Type IIRadiation-Sensitizing AgentsBreast NeoplasmsEnzyme InhibitorsDaunorubicinTopoisomerase I InhibitorsDrug Evaluation, PreclinicalPlant ExtractsNanoparticlesCosmic RadiationNanomedicineRadiation Injuries, ExperimentalTime FactorsFluorouracilPlatinumGene Expression Regulation, NeoplasticRadiometryNanocapsulesDrug DiscoveryColonic NeoplasmsAntimetabolites, AntineoplasticRadiation PneumonitisNeoplasms, Radiation-InducedCombined Modality TherapyOrganoplatinum CompoundsCaspasesRadiotherapy DosageRadiotherapyNeoplasms, ExperimentalUltraviolet RaysNeoplasm TransplantationTumor Suppressor Protein p53MitomycinMitoxantroneDNAAntineoplastic Combined Chemotherapy ProtocolsCaspase 3Molecular Targeted TherapyDrugs, InvestigationalDNA RepairProto-Oncogene Proteins c-bcl-2Background RadiationSignal TransductionDNA AdductsAntineoplastic Agents, AlkylatingMultidrug Resistance-Associated ProteinsCell DivisionIntercalating AgentsCell DeathDrug ResistanceNeoplasm ProteinsLeukemia P388XanthonesStructure-Activity RelationshipHT29 CellsLung NeoplasmsMCF-7 CellsHCT116 Cells